View in EDS PDF Full Text

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.

Saved in:
Bibliographic Details
Title: Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.
Authors: Bazargan S; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Bunch B; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Ojwang' AME; Department of Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, United States., Blauvelt J; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Landin A; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Ali J; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Abrahams D; Comparative Medicine, University of South Florida, Tampa, FL, United States., Cox C; Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL, United States., Hall AM; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Beatty MS; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Poch M; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, United States., Rejniak KA; Department of Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, United States., Pilon-Thomas S; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Oct 12; Vol. 14, pp. 1275375. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2023.1275375